These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34858228)

  • 21. Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial.
    Wang Z; Xu X; Tan Q; Li K; Ma C; Xie S; Gao C; Wang G; Li H
    Shanghai Arch Psychiatry; 2015 Aug; 27(4):228-36. PubMed ID: 26549959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of esmirtazapine in adult outpatients with chronic primary insomnia: a randomized, double-blind placebo-controlled study and open-label extension.
    Ivgy-May N; Hajak G; van Osta G; Braat S; Chang Q; Roth T
    J Clin Sleep Med; 2020 Sep; 16(9):1455-1467. PubMed ID: 32351205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine versus placebo in the treatment of major depressive disorder and associated painful physical symptoms: a replication study.
    Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Hann D; Marangell LB
    Curr Med Res Opin; 2011 Oct; 27(10):1859-67. PubMed ID: 21838410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Has the symptom severity inclusion requirement narrowed the definition of major depressive disorder in antidepressant efficacy trials?
    Zimmerman M; Walsh E; Chelminski I; Dalrymple K
    J Affect Disord; 2017 Mar; 211():60-64. PubMed ID: 28088058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.
    Detke MJ; Lu Y; Goldstein DJ; McNamara RK; Demitrack MA
    J Psychiatr Res; 2002; 36(6):383-90. PubMed ID: 12393307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
    Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
    J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Transcranial Alternating Current Stimulation for the Treatment of Chronic Insomnia: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial.
    Wang HX; Wang L; Zhang WR; Xue Q; Peng M; Sun ZC; Li LP; Wang K; Yang XT; Jia Y; Zhou QL; Xu ZX; Li N; Dong K; Zhang Q; Song HQ; Zhan SQ; Min BQ; Fan CQ; Zhou AH; Guo XH; Li HB; Liang LR; Yin L; Si TM; Huang J; Yan TY; Cosci F; Kamiya A; Lu J; Wang YP
    Psychother Psychosom; 2020; 89(1):38-47. PubMed ID: 31846980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of low-dose amitriptyline and mirtazapine for insomnia disorder: study protocol of a randomised, double-blind, placebo-controlled trial in general practice (the DREAMING study).
    Bakker MH; Hugtenburg JG; van Straten A; van der Horst HE; Slottje P
    BMJ Open; 2021 Sep; 11(9):e047142. PubMed ID: 34475156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL; Goldstein DJ; Mallinckrodt C; Lu Y; Detke MJ
    Depress Anxiety; 2003; 18(2):53-61. PubMed ID: 12964171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study.
    Langade D; Kanchi S; Salve J; Debnath K; Ambegaokar D
    Cureus; 2019 Sep; 11(9):e5797. PubMed ID: 31728244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.
    Fornaro M; Martino M; Mattei C; Prestia D; Vinciguerra V; De Berardis D; De Pasquale C; Iasevoli F; Mungo S; Fornaro P
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1269-78. PubMed ID: 24842649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial.
    Zhou QH; Wang HL; Zhou XL; Xu MB; Zhang HF; Huang LB; Zheng GQ; Lin Y
    BMJ Open; 2017 Apr; 7(4):e014280. PubMed ID: 28377394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies.
    Trivedi MH; Bandelow B; Demyttenaere K; Papakostas GI; Szamosi J; Earley W; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1733-44. PubMed ID: 23673347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Morokuma I; Katsuki F; Fujita H; Sasaki M; Kawamura C; Perlis ML
    J Clin Psychiatry; 2011 Dec; 72(12):1651-8. PubMed ID: 21457679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing the Effects of Sertraline with Duloxetine for Depression Severity and Symptoms: A Double-Blind, Randomized Controlled Trial.
    Mowla A; Dastgheib SA; Razeghian Jahromi L
    Clin Drug Investig; 2016 Jul; 36(7):539-43. PubMed ID: 27071759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
    Manber R; Buysse DJ; Edinger J; Krystal A; Luther JF; Wisniewski SR; Trockel M; Kraemer HC; Thase ME
    J Clin Psychiatry; 2016 Oct; 77(10):e1316-e1323. PubMed ID: 27788313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.